Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies.
Journal Information
Full Title: Ther Adv Drug Saf
Abbreviation: Ther Adv Drug Saf
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."
"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Medical Research Centre program [grant number NRF-2018 R1A5A2023879], the Basic Science Research Programme [grant number NRF-2020 R1C1C1003741] through a National Research Foundation of Korea grant funded by the Korean government."
"This meta-analysis was conducted in accordance with PRISMA guidelines. The study protocol is registered with PROSPERO (registration no: CRD42021231789)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025